PMID: 2490833May 1, 1989Paper

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

Hypertension
N B ShulmanK A Schneider

Abstract

The Hypertension Detection and Follow-up Program followed up 10,940 persons for 5 years in a community-based, randomized, controlled trial of treatment for hypertension. Participants were randomized to one of two treatment groups, stepped care and referred care. The primary end point of the study was all-cause mortality, with morbid events involving the heart, brain, and kidney as secondary end points. Loss of renal function, ascertained by a change in serum creatinine, was among these secondary events. Baseline serum creatinine concentration had a significant prognostic value for 8-year mortality. For persons with a serum creatinine concentration greater than or equal to 1.7 mg/dl, 8-year mortality was more than three times that of all other participants. The estimated 5-year incidence of substantial decline in renal function was 21.7/1,000 in the stepped-care group and 24.6/1,000 in the referred-care group. Among persons with a baseline serum creatinine level between 1.5 and 1.7 mg/dl, the 5-year incidence of decline was 113.3/1,000 (stepped care) and 226.6/1,000 (referred care) (p less than 0.01). The incidence of decline in renal function was greater in men, blacks, and older adults, as well as in those with higher entry di...Continue Reading

Associated Clinical Trials

References

Feb 1, 1978·American Journal of Public Health·J S MausnerH Menduke
May 30, 1977·JAMA : the Journal of the American Medical Association
Jan 28, 1988·The New England Journal of Medicine·P W Eggers
Apr 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W B Blythe
Apr 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S Baldwin, J Neugarten
Apr 1, 1985·Journal of the American Geriatrics Society·R D LindemanN W Shock
Jan 1, 1971·British Heart Journal·O Paul
Jul 1, 1983·American Journal of Epidemiology·J D CurbC M Hawkins
May 27, 1982·The New England Journal of Medicine·S G RostandB A Pate
Aug 1, 1982·American Journal of Public Health·R A Hiatt, G D Friedman
Dec 1, 1958·Journal of Chronic Diseases·S J CUTLER, F EDERER
May 1, 1950·Proceedings of the Society for Experimental Biology and Medicine·R S HARE

❮ Previous
Next ❯

Citations

May 1, 1993·Journal of Clinical Pharmacology·K C Abbott, G Bakris
Aug 5, 2008·Wiener medizinische Wochenschrift·Katharina Hohenstein, Bruno Watschinger
Oct 12, 2012·International Urology and Nephrology·Agata Kujawa-SzewieczekGrzegorz Piecha
Oct 16, 2002·Current Cardiology Reports·Julián SeguraLuis M Ruilope
May 17, 2001·Current Hypertension Reports·L M Ruilope, J Garcia-Puig
Jul 8, 2003·Current Hypertension Reports·Luis M Ruilope
Nov 6, 2004·Current Hypertension Reports·James P Smith, Julia B Lewis
Mar 28, 2008·Current Hypertension Reports·Yousri M Barri
Sep 10, 2009·Current Hypertension Reports·Bassam G Abu Jawdeh, Mahboob Rahman
Nov 10, 2011·Current Hypertension Reports·Barry I Freedman, Mariana Murea
Jul 16, 2002·Current Hypertension Reports·Luis M Ruilope, Julian Segura
Sep 12, 2000·Current Hypertension Reports·R K Wali, M R Weir
Dec 5, 2012·Journal of Cardiovascular Translational Research·Paul F StahlsT Cooper Woods
Dec 1, 1991·Controlled Clinical Trials·L A Moyé
Mar 24, 2007·The American Journal of Cardiology·Chamberlain I Obialo
Sep 16, 2003·The American Journal of Cardiology·Claudia U ChaeGary C Curhan
Aug 7, 1999·The American Journal of Cardiology·A Zanchetti
Jul 29, 1998·Disease-a-month : DM·R R Townsend, M Cirigliano
Mar 25, 1995·Lancet·S MadhavanM H Alderman
Aug 31, 2001·Journal of the American College of Cardiology·M G ShlipakUNKNOWN Heart and Estrogen/progestin Replacement Study (HERS) Investigators
Dec 12, 2001·Journal of the American College of Cardiology·L M RuilopeT F Luscher
Dec 12, 2001·Journal of the American College of Cardiology·P VerdecchiaUNKNOWN MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group
Feb 7, 2003·Journal of the American College of Cardiology·Guruprasad ManjunathMark J Sarnak
Nov 30, 2000·Anesthesiology Clinics of North America·J SprungJ F O'Hara
Sep 28, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kei YokotaKazuomi Kario
Oct 20, 2011·Nature Reviews. Nephrology·Barry I Freedman, Donald W Bowden
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Jennifer J GassmanShin-Ru Wang
Nov 26, 2003·Journal of the American Society of Nephrology : JASN·Joachim H IxMary A Whooley
Jan 11, 2013·Journal of Hypertension·Stacie L DaughertyDavid J Magid
Jan 7, 2010·Current Opinion in Nephrology and Hypertension·Mariana Murea, Barry I Freedman
Apr 11, 2012·Current Opinion in Nephrology and Hypertension·Tamara Isakova
Sep 8, 2010·Clinical and Experimental Pharmacology & Physiology·Hiroe TobaTetsuo Nakata
Oct 22, 2011·Clinical and Experimental Pharmacology & Physiology·Shan LiuHenry Krum
Dec 1, 1994·Australian and New Zealand Journal of Medicine·J H StewartT H Mathew
Oct 9, 2002·The Journal of Clinical Hypertension·Julían SeguraLuis M Ruilope
Jan 10, 2006·Seminars in Dialysis·Herwig-Ulf Meier-Kriesche, Jesse D Schold
Jun 9, 2007·Seminars in Dialysis·Scott G SatkoBarry I Freedman
May 23, 2006·BMJ : British Medical Journal·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
Mar 24, 2005·American Journal of Nephrology·Alain BaumelouGilbert Deray
Jun 27, 2008·American Journal of Nephrology·Pamela J HicksBarry I Freedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.